Connect to other sites within the UBM Medica Network
Four questions for you to answer, four facts you need to know.
GLP-1: Used Only as Needed
The ADA recommends GLP-1 agonists as second-line therapy against type 2 diabetes. What makes this class unique in its impact on hyperglycemia?
Why Do Endocrinologists Burn Out?
Our endo blogger has her theories about why doing what you thought you loved just seems to sap your soul.
A 61-year-old Man with Diabetes and Resistant Hypertension
There are several reasonable options for intensifying this patient's blood pressure treatment. Which one is optimal, though, given his labs and concomitant meds?
Abridged Diabetes Guidelines for Primary Care: 6 Noteworthy Changes
The ADA provides an abridged version for PCPs of its annual Standards of Medical Care. Our slides summarize 6 updates important to primary care.
I'm a DO--And My Day Job Is Teaching
“Doctor” comes from the Latin docēre, “to teach.”
Metformin Trims Colorectal Cancer Risk in Diabetes
The drug appeared to reduce the risk in the first study to assess its effects on younger patients with diabetes in the United States.
Have You Heard This (Week's) News?
Microbes in the gut affect metabolic pathways involved in the pathogenesis of obesity, insulin resistance, and diabetes. Antibiotics can alter gut microbiota.
Five Top Papers From 2014 That Will Impact Your Practice
New drugs that treat stubborn illness seen often in primary care lead this group of Top 5 Papers for 2014. Type 2 diabetes, cryptogenic stroke, and hep-C are key targets.
By clicking Accept, you agree to become a member of the UBM Medica Community.